Modus Therapeutics Holding Future Growth
Future criteria checks 0/6
Modus Therapeutics Holding's earnings are forecast to decline at 28.8% per annum. EPS is expected to decline by 10.3% per annum.
Key information
-28.8%
Earnings growth rate
-10.3%
EPS growth rate
| Biotechs earnings growth | 38.9% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 28 Feb 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2023 | N/A | -18 | -17 | -17 | N/A |
| 9/30/2023 | N/A | -23 | -22 | -22 | N/A |
| 6/30/2023 | N/A | -23 | -22 | -22 | N/A |
| 3/31/2023 | N/A | -21 | -21 | -21 | N/A |
| 12/31/2022 | N/A | -18 | -22 | -22 | N/A |
| 9/30/2022 | N/A | -21 | -22 | -22 | N/A |
| 6/30/2022 | N/A | -23 | -23 | -23 | N/A |
| 3/31/2022 | N/A | -22 | -22 | -22 | N/A |
| 12/31/2021 | N/A | -21 | -16 | -16 | N/A |
| 9/30/2021 | N/A | -9 | -9 | -9 | N/A |
| 6/30/2021 | N/A | -6 | -6 | -6 | N/A |
| 3/31/2021 | N/A | -5 | -5 | -5 | N/A |
| 12/31/2020 | N/A | -6 | -7 | -7 | N/A |
| 12/31/2019 | N/A | -44 | -48 | -48 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MODTX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: MODTX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: MODTX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: Insufficient data to determine if MODTX's revenue is forecast to grow faster than the Swedish market.
High Growth Revenue: Insufficient data to determine if MODTX's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if MODTX's Return on Equity is forecast to be high in 3 years time